Grants and Contributions:
Title:
Quantum technology enabled blood diagnostics for safer and more patient centric cancer care & treatment management
Agreement Number:
1011593
Agreement Value:
$338,250.00
Agreement Date:
Nov 23, 2020 - Oct 31, 2025
Description:
Cancer therapy relies on understanding each patient's unique cancer type
and its progression. However, this is challenging due to cancer's
complexity. Doctors need user-friendly tools to identify a patient's specific
cancer fingerprint for precise drug selection. Emerging targeted drugs
require accurate cancer matching.
Scientists have found that tumors release circulating cancer cells into the
blood, enabling liquid biopsies through simple blood tests. A UK company,
Beyond Blood, is developing an innovative diagnostic machine to count
different blood cells automatically. The project will involve the University of
Calgary and the NRC testing the detection of Quantum Dots using single
photon level cameras and microfluidic systems for the development of
advanced diagnostic systems, particularly for cancer management. If the
Quantum dot single photon level cameras are successful, AQM (a
Canadian Company) and Beyond Blood (a UK company) will look to test
the technology in their specialized cell detection systems. If these
components technologies can be brought together, the resultant platform
will have a profound impact on cancer care, patient wellbeing and health
care systems globally.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Calgary, Alberta, CA T2N 1N4
Reference Number:
172-2023-2024-Q3-1011593
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
108102864
Recipient Type:
Academia
Recipient's Legal Name:
The Governors of the University of Calgary
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710